vTv Therapeutics Inc. Annual Income Tax Expense (Benefit) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
vTv Therapeutics Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • vTv Therapeutics Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • vTv Therapeutics Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $100K.
  • vTv Therapeutics Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000, a 100% decline from 2022.
  • vTv Therapeutics Inc. annual Income Tax Expense (Benefit) for 2022 was $200K, a 73.9% increase from 2021.
  • vTv Therapeutics Inc. annual Income Tax Expense (Benefit) for 2021 was $115K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$200K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $200K +$85K +73.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $115K +$115K Jan 1, 2021 Dec 31, 2021 10-K 2024-03-13
2020 $0 -$100K -100% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $100K -$100K -50% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-29
2018 $200K -$600K -75% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $800K +$800K Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $0 $0 Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.